INTERNATIONAL PATENT: BIOVENTURES, LLC FILES APPLICATION FOR "NEUROVASCULAR PROTECTION WITH THERAPEUTIC TARGETING OF CD47 / SIRPA AXIS USING NEUTRALIZING ANTIBODIES"

GENEVA, Nov. 5 -- BIOVENTURES, LLC (4301 W. Markham St., #831Little Rock, AR 72205-7199) filed a patent application (PCT/US2025/026460) for "NEUROVASCULAR PROTECTION WITH THERAPEUTIC TARGETING OF CD47 / SIRPA AXIS USING NEUTRALIZING ANTIBODIES" on Apr 25, 2025. With publication no. WO/2025/227083, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FOUDA, Abdelrahman (c/o Bioventures, LLC4301 W. Markham St., #831Little Rock, AR 72205-7199)

Abstract: The present invention provides methods of treating ischemic and traumatic ce...